IPO Information & documents
Investor centre
Additional resources
Admission of Over-allotment Option Shares
8th October 2021 | PDF
Announcement of Admission to trading
5th October 2021 | PDF
Exercise of Over-allotment Option
5th October 2021 | PDF
Prospectus summary
30th September 2021 | PDF
Announcement of Approval and Publication of Prospectus
30th September 2021 | PDF
Accountants report on Historical Financial Information
30th September 2021 | PDF
Articles of Association of Oxford Nanopore Technologies plc (on Admission)
30th September 2021 | PDF
Deloitte consent letter (Prospectus)
30th September 2021 | PDF
DeciBio Prospectus Consent Letter
30th September 2021 | PDF
Health Advances Consent Letter (Prospectus)
30th September 2021 | PDF
Pricing Statement
30th September 2021 | PDF
Confirmation of Intention to Float
16th September 2021 | PDF
Financial Conduct Authority Approves Registration Document
13th September 2021 | PDF
Registration Document
9th September 2021 | PDF
Expected Intention To Float
9th September 2021 | PDF
Articles of Association for Oxford Nanopore Technologies Limited
9th September 2021 | PDF
Oxford Nanopore Technologies Limited Historical Financial Information
9th September 2021 | PDF
Accountants report on the Historical Financial Information
9th September 2021 | PDF
DeciBio Report
9th September 2021 | PDF
Health Advances Report
9th September 2021 | PDF
Deloitte LLP consent letter
9th September 2021 | PDF
DeciBio consent letter
9th September 2021 | PDF
Health Advances consent letter
9th September 2021 | PDF
